View all research projects

Research project

Cragg. LLR. 12050. Optimising antibody therapy for Lymphoma.

Research groups:
Lead researcher:

Professor Mark Cragg
Other researchers:

Professor Stephen Beers,

Professor Jon Strefford,

Professor Peter Johnson
Research funder:

Blood Cancer UK
Status:

Not active

Staff

Lead researcher

Professor Mark Cragg

Professor Mark Cragg

Professor in Experimental Cancer Biology

Research interests

Antibody biology
Antibody engineering
Cancer Immunotherapy

Email: m.s.cragg@soton.ac.uk

Other researchers

Professor Stephen Beers

Professor Stephen Beers

Professor of Immunology & Immunotherapy

Research interests

Edit
Antibody Effector Functions Monoclonal antibodies (mAb) have become established in the treatment of a variety of malignancies - transforming patient outcomes. Despite this undoubted impact, responses remain variable and their mechanisms of action and of tumour resistance are controversial. Our research is focussed on understanding these complex processes using a variety of complementary models and systems to better inform antibody selection, design and clinical application.
Current research interests:

Email: s.a.beers@soton.ac.uk

Professor Jon Strefford

Professor Jon Strefford PhD

Head of School

Email: jcs@soton.ac.uk

Professor Peter Johnson

Professor Peter Johnson CBE MD FRCP FMedSci

Professor of Medical Oncology

Email: johnsonp@soton.ac.uk

Collaborating research institutes, centres and groups

Cancer Sciences

Our research works towards improving treatment for patients with cancer.

Back to top